-
公开(公告)号:EP4368637A3
公开(公告)日:2024-07-10
申请号:EP24161007.0
申请日:2017-05-19
发明人: VORONINA, Vera , MACDONALD, Lynn , PRISSETTE, Marine , LAI, Ka-Man Venus , BADITHE, Ashok , MURPHY, Andrew J. , DROGUETT, Gustavo , FRENDEWEY, David , ZAMBROWICZ, Brian
IPC分类号: A01K67/027 , C07K16/18 , C12N15/90 , C12N15/85 , C07K16/00
CPC分类号: A01K67/0276 , C12N15/90 , A01K2217/0020130101 , A01K2217/07520130101 , A01K2267/0220130101 , C07K2317/2120130101 , C07K2317/2420130101 , C07K2317/3320130101 , C07K16/00 , A01K67/0278 , A01K2207/1520130101 , A01K2217/1520130101 , A01K2227/10520130101 , A01K2267/0120130101 , C12N9/6489 , C12N15/8509 , C12N2015/851820130101 , C12Y301/00 , C12Y304/24046 , C12N2310/2020170501
摘要: Methods and compositions are provided for making non-human animals with reduced tolerance of a foreign antigen of interest and making antigen-binding proteins against that foreign antigen of interest using such animals. The methods and compositions employ CRISPR/Cas9 systems using multiple guide RNAs to reduce or eliminate expression of a self-antigen homologous to or sharing an epitope of interest with the foreign antigen of interest or to reduce or eliminate expression of an epitope on the self-antigen that is shared with the foreign antigen of interest.
-
2.
-
公开(公告)号:EP4368637A2
公开(公告)日:2024-05-15
申请号:EP24161007.0
申请日:2017-05-19
发明人: VORONINA, Vera , MACDONALD, Lynn , PRISSETTE, Marine , LAI, Ka-Man Venus , BADITHE, Ashok , MURPHY, Andrew J. , DROGUETT, Gustavo , FRENDEWEY, David , ZAMBROWICZ, Brian
IPC分类号: C07K16/00
CPC分类号: A01K67/0276 , C12N15/90 , A01K2217/0020130101 , A01K2217/07520130101 , A01K2267/0220130101 , C07K2317/2120130101 , C07K2317/2420130101 , C07K2317/3320130101 , C07K16/00 , A01K67/0278 , A01K2207/1520130101 , A01K2217/1520130101 , A01K2227/10520130101 , A01K2267/0120130101 , C12N9/6489 , C12N15/8509 , C12N2015/851820130101 , C12Y301/00 , C12Y304/24046 , C12N2310/2020170501
摘要: Methods and compositions are provided for making non-human animals with reduced tolerance of a foreign antigen of interest and making antigen-binding proteins against that foreign antigen of interest using such animals. The methods and compositions employ CRISPR/Cas9 systems using multiple guide RNAs to reduce or eliminate expression of a self-antigen homologous to or sharing an epitope of interest with the foreign antigen of interest or to reduce or eliminate expression of an epitope on the self-antigen that is shared with the foreign antigen of interest.
-
-